← Leaderboards
Richard J Santen
University Of Virginia Charlottesville
$6,002,791
Attributed
$6,586,720
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $648.4K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,586,720 · 5
By mechanism
R01$6,185,358 · 3
M01$401,362 · 2
Top collaborators
- Ian Alexander Blair2 shared
- Daniel F. Heitjan2 shared
- Eldon R Jupe2 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Sarah J Parsons$11,850,077
Others in their field
Top investigators on “Estradiol”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Howard N Hodis · University Of Southern California$33,854,516
- Susan E. Hankinson · University Of Massachusetts Amherst$21,840,077
- Richard A. Miller · University Of Michigan At Ann Arbor$21,401,310
- Randy Strong · South Texas Veterans Health Care System$16,538,882
- Eugene D Albrecht · University Of Maryland Baltimore$15,534,692
Research focus
EstradiolHormone TherapyApoptosisGrowth FactorMcf7 CellMitogen Activated Protein KinaseEstrogensEnzyme Linked Immunosorbent AssayHypersensitivityCell CycleEstrogen ReceptorsBreast NeoplasmsHormone Related Neoplasm /CancerTranscription FactorFemaleTamoxifenPathway InteractionsWomanHuman Therapy EvaluationClinical ResearchHormone Sensitivity /ResistancePostmenopauseHuman SubjectCessation Of Life
Grant awards (26)
Development of Breast Cancer Risk Model Based on Estrogen Metabolomics$335,808
R01 · FY2013 · CA · contact PI
Development of Breast Cancer Risk Model Based on Estrogen Metabolomics$442,764
R01 · FY2012 · CA · contact PI
Determinants of Tissue Estradiol Sensitivity$267,498
R01 · FY2009 · CA · contact PI
Role of the Cell Cycle in Hypersensitivity to Estradiol$325,345
R01 · FY2008 · CA · contact PI
Determinants of Tissue Estradiol Sensitivity$268,655
R01 · FY2008 · CA · contact PI
Role of the Cell Cycle in Hypersensitivity to Estradiol$325,345
R01 · FY2007 · CA · contact PI
Determinants of Tissue Estradiol Sensitivity$269,779
R01 · FY2007 · CA · contact PI
Role of the Cell Cycle in Hypersensitivity to Estradiol$335,062
R01 · FY2006 · CA · contact PI
Determinants of Tissue Estradiol Sensitivity$278,962
R01 · FY2006 · CA · contact PI
Role of the Cell Cycle in Hypersensitivity to Estradiol$343,125
R01 · FY2005 · CA
Determinants of Tissue Estradiol Sensitivity$305,288
R01 · FY2005 · CA
Role of the Cell Cycle in Hypersensitivity to Estradiol$342,188
R01 · FY2004 · CA
ROLE OF THE CELL CYCLE IN HYPERSENSITIVITY TO ESTRADIOL$299,592
R01 · FY2003 · CA
DETERMINANTS OF TISSUE ESTRADIOL SENSITIVITY$296,000
R01 · FY2003 · CA
DETERMINANTS OF TISSUE ESTRADIOL SENSITIVITY$296,000
R01 · FY2002 · CA
ROLE OF THE CELL CYCLE IN HYPERSENSITIVITY TO ESTRADIOL$292,823
R01 · FY2002 · CA
TREATMENT OF UROGENITAL ATROPHY WITH LOW DOSE VAGINAL ESTRADIOL$48,533
M01 · FY2002 · RR
DETERMINANTS OF TISSUE ESTRADIOL SENSITIVITY$296,000
R01 · FY2001 · CA
ROLE OF THE CELL CYCLE IN HYPERSENSITIVITY TO ESTRADIOL$286,252
R01 · FY2001 · CA
TREATMENT OF UROGENITAL ATROPHY WITH LOW DOSE VAGINAL ESTRADIOL$48,533
M01 · FY2001 · RR
ROLE OF THE CELL CYCLE IN HYPERSENSITIVITY TO ESTRADIOL$291,872
R01 · FY2000 · CA
DETERMINANTS OF TISSUE ESTRADIOL SENSITIVITY$287,000
R01 · FY2000 · CA
ANASTRAZOLE$248,088
M01 · FY2000 · RR
TREATMENT OF UROGENITAL ATROPHY WITH LOW DOSE VAGINAL ESTRADIOL$28,104
M01 · FY2000 · RR
ANASTRAZOLE$28,104
M01 · FY2000 · RR
TREATMENT OF UROGENITAL ATROPHY WITH LOW DOSE VAGINAL ESTRADIOL$0
M01 · FY2000 · RR